Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.

Autor: Dhakal, Prajwal1,2 prajwal-dhakal@uiowa.edu, Sy, Mario1,2, Sutamtewagul, Grerk1,2, Mou, Eric1,2, Nanmeng Yu1,2, Pemmaraju, Naveen3
Zdroj: Journal of Immunotherapy & Precision Oncology. Aug2024, Vol. 7 Issue 3, p205-209. 5p.
Databáze: Academic Search Ultimate